Herpes Simplex Virus 2 (IgG), Type Specific Antibody (HerpeSelect®) - (QUEST DIAGNOSTICS)
Description: Herpes simplex virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningo-encephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV type 2 is more commonly associated with genital tract and neonatal infections, while HSV type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients.
It is recommended to have follow-up testing performed in 4 weeks, when Negative test results are received and possible exposure has occurred. Positive results may require further evaluation by your physician.
Includes: Herpes Simplex Virus 2 (IgG), Type Specific Antibody (HerpeSelect®)
Herpes Simplex Virus (HSV) Type II IgG - (LABCORP)
Description: The most common type of genital herpes is caused by HSV-2 (Herpes Simplex Virus (HSV) Type II). Symptoms include blisters around the genitals or rectum, although some individuals may not display symptoms at all. Genital herpes STD blood testing can help uncover and identify this disease in your system.
The HSV Type II IgG test is appropriate for exposure at least 4 weeks prior to testing. Positive results may require further evaluation by your physician.
Includes: Herpes Simplex Virus (HSV) Type 2-Specific Antibodies, IgG With Reflex to Supplemental Testing on positive